We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
The combination of bemnifosbuvir and ruzasvir reduces the treatment course for hepatitis C from 12 to 7–8 weeks. Learn about trial results and benefits of the new regimen.
